![NETEC Resource Library](https://repository.netecweb.org/files/theme_uploads/400508e2d5d16a4cdb990b4486af9b3f.png)
Search Instructions:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Search (685 total)
- Query: COVID
- Query type: Keyword
- Record types:
- Item
- Exhibit
- Simple Page
Record Type | Title | Thumbnail | Subject | Date Published | Description |
---|---|---|---|---|---|
Item | Patient Trajectories Among Persons Hospitalized for COVID-19 : A Cohort Study | Treatment & Care | 2020-09-22 | Risk factors for progression of coronavirus 2019 (COVID-19) to severe disease or death are underexplored in U.S. cohorts. | |
Item | Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study | Research | 2020-03-18 | Since the outbreak of coronavirus disease 2019 (COVID-19) in December2019, various digestive symptoms have been frequently reported in patients infected with the virus. | |
Item |
![]() |
Clinical Course of COVID-19 in a Liver Transplant Recipient on Hemodialysis and Response to Tocilizumab Therapy: A Case Report. | Research | 2020-05-02 | The novel coronavirus disease 2019 (COVID-19) is a highly infectious and rapidly spreading disease. There are limited published data on the epidemiology and outcomes of COVID-19 infection among organ transplant recipients. |
Item |
![]() |
PPE (ACE) double gloves | Infection Control | 2020-08-28 | COVID-19 Unit Resources: COVID-19 Unit - COVID-19 ACE Printable PDFs (RE-USE GOWN). RE-USE GOWN, DOUBLE Gloves - COVID-19 Unit - ACE Printable PDFs Putting ON PPE, Extending Wear, Taking OFF PPEThese PDFs reflect the current supply shortage in which N95 masks and face shields and gowns may be…
Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution. |
Item |
![]() |
Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study | Research | 2020-06-08 | COVID-19 is characterised by respiratory symptoms, which deteriorate into respiratory failure in a substantial proportion of cases, requiring intensive care in up to a third of patients admitted to hospital. Analysis of the pathological features in the lung tissues of patients who have died with… |
Item |
![]() |
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19 | Research | 2020-11-19 | Hydroxychloroquine and azithromycin have been used to treat patients with coronavirus disease 2019 (Covid-19). However, evidence on the safety and efficacy of these therapies is limited. |
Item | Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine | Research | 2020-12-10 | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the resulting coronavirus disease 2019 (Covid-19) have afflicted tens of millions of people in a worldwide pandemic. Safe and effective vaccines are needed urgently. | |
Item | Prevalence of Co-infection at the Time of Hospital Admission in COVID-19 Patients, A Multicenter Study | Research | 2020-12-21 | Bacterial infections may complicate viral pneumonias. Recent reports suggest that bacterial co-infection at time of presentation is uncommon in coronavirus disease 2019 (COVID-19); however, estimates were based on microbiology tests alone. We sought to develop and apply consensus definitions,… | |
Item | Association Between Chronic Use of Immunosuppresive Drugs and Clinical Outcomes From Coronavirus Disease 2019 (COVID-19) Hospitalization: A Retrospective Cohort Study in a Large US Health System | Research | 2021-01-07 | It is unclear whether chronic use of immunosuppressive drugs worsens or improves the severity of coronavirus disease 2019 (COVID-19), with plausible mechanisms for both. | |
Item |
![]() |
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine | Research | 2021-02-04 | Vaccines are needed to prevent coronavirus disease 2019 (Covid-19) and to protect persons who are at high risk for complications. The mRNA-1273 vaccine is a lipid nanoparticle–encapsulated mRNA-based vaccine that encodes the prefusion stabilized full-length spike protein of the severe acute… |